ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience

    P. Vuong, L. Lee, N. Mineyev, S. Conlon, R. Shetty, W. Concepcion, C. A. Bonham, A. Gallo, T. Pham, S. Busque, M. L. Melcher, G. M. Enns, C. O. Esquivel

    Stanford University Medical Center, Palo Alto, CA

    *Purpose: Liver transplantation (LT) for acute and chronic end-stage-liver-disease is a well-accepted therapy in pediatrics. However, for children with metabolic disorders (MD) without intrinsic liver…
  • 2019 American Transplant Congress

    Complete Robotic-Assisted Kidney Transplantation: Our Initial Experience

    A. Khan, C. Bhati, T. Reichman, A. Cotterell, D. Kumar, G. Gupta, L. Kamal, A. King, A. Sharma, M. Levy

    VCU Medical Center, Richmond, VA

    *Purpose: Kidney transplantation is the standard treatment for patients with ESRD. Very limited advancement has been made in its surgical aspects. Minimal invasive approach for…
  • 2019 American Transplant Congress

    Ex Vivo Assessment of Marginal Human Kidneys Using Computed Tomography

    M. K. Harris1, J. R. DiRito2, H. Liu3, N. Boutagy3, C. Liu4, S. Hosgood2, D. Mulligan1, M. L. Nicholson2, A. Sinusas3, D. Haakinson1, G. T. Tietjen1

    1Surgery, Yale School of Medicine, New Haven, CT, 2Surgery, University of Cambridge, Cambridge, United Kingdom, 3Yale Translational Research Imaging Center, New Haven, CT, 4Radiology, Yale School of Medicine, New Haven, CT

    *Purpose: Thousands of ‘marginal’ organs are discarded each year despite a severe organ shortage. This has motivated development of new technologies, such as ex vivo…
  • 2019 American Transplant Congress

    Breaking Concepts: 10-year Follow-Up of the Everolimus versus Azathioprine Heart Transplant Multi-National Study

    J. A. Kobashigawa1, R. Starling2, E. Passano1, P. Bernhardt3, B. Azarbal1, R. Cheng1, F. Esmailian1, K. Khush4, D. Mancini5, J. Patel1, T. Sato1, S. Varnous6

    1Smidt Heart Institute at Cedars-Sinai, Los Angeles, CA, 2Cleveland Clinic, Cleveland, OH, 3Novartis Pharmaceuticals, Basel, Switzerland, 4Stanford University, Palo Alto, CA, 5Mount Sinai, New York, NY, 6APHP, Pitié‐Salpétrière, Sorbonne University, Paris, France

    *Purpose: This study is the 10-year follow-up of a randomized double-blind prospective trial that compared everolimus (1.5 mg or 3 mg) to azathioprine. In this…
  • 2019 American Transplant Congress

    Development and Validation of a Capillary Blood Mitra-Based Assay for the Quantitative Determination of Advagraf® Concentrations in Transplant Patients

    N. Undre1, I. Dawson2, V. Aluvihare3, N. Kamar4, F. Saliba5, N. Torpey6, S. Anaokar7, G. Kazeem1

    1Astellas Pharma Europe Ltd, Chertsey, United Kingdom, 2Covance Laboratories, Harrogate, United Kingdom, 3Kings College Hospital, London, United Kingdom, 4CHU Rangueil, Toulouse, France, 5Hôpital Paul-Brousse, Villejuif, France, 6Addenbrookes Hospital, Cambridge, United Kingdom, 7Astellas Pharma Europe Ltd, Surrey, United Kingdom

    *Purpose: Therapeutic drug monitoring of tacrolimus (TAC) requires venepuncture blood samples taken by specialists, requiring patients to attend an outpatient clinic; this can be inconvenient…
  • 2019 American Transplant Congress

    Renal Cell Carcinoma in Dialysis Patients: Criteria for Transplant Wait List Inclusion

    D. B. Laskar1, J. Zeng1, S. Sharma2, M. T. Smith Jr3, A. D. Nicastri1, D. Levitan4, R. Maglantay1, D. John3, S. R. Gottesman1

    1Pathology, SUNY Downstate Medical Center, Brooklyn, NY, 2Transplant Surgery, NYP/Columbia University Medical Center, New York, NY, 3Surgery, SUNY Downstate Medical Center, Brooklyn, NY, 4Pathology & Laboratory Medicine, NYP/Weill Cornell Medical Center, New York, NY

    *Purpose: End-stage renal disease (ESRD) patients on long-term hemodialysis have a higher incidence of renal cell carcinoma (RCC) in their native kidneys than the general…
  • 2019 American Transplant Congress

    The Pregnancy Experiences of Uterus Transplant Recipients

    A. E. Wall, L. Johannesson, G. Testa, A. Warren

    Baylor University Medical Center, Dallas, TX

    *Purpose: The purpose of this study was to explore the pregnancy experiences of uterus transplant recipients through semi-structured interviews so as to develop a better…
  • 2019 American Transplant Congress

    Effects of Pretreated Bortezomib on Renal Function after Renal Ischemia – Reperfusion Injury in Mice

    X. Zheng

    Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    *Purpose: To observe the effects of pretreated bortezomib at different points on renal function and renal histology after renal ischemia-reperfusion injury in mice.*Methods: A mice…
  • 2019 American Transplant Congress

    Perioperative Blood Transfusion Significantly Increases Inpatient Morbidity and Mortality in Renal Transplant Recipients: 15-year Experience

    K. Mahendraraj1, G. Medrano del Rosal1, M. Kruse1, R. Shah1, T. Katsichtis1, T. Brennan2, N. Nissen2, T. Todo2, K. Kosari2, A. Klein2, I. Kim2

    1Surgery, Lincoln Medical Center, New York, NY, 2Transplant Surgery, Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: This study evaluates the immediate effects of perioperative blood transfusion (PBT) on inpatient morbidity and mortality among renal transplant (RT) recipients during their index…
  • 2019 American Transplant Congress

    The Therapeutic Potential of Ex Vivo Induced Monocytic Myeloid-Derived Suppressor Cells from Bone Marrow in a Mouse Cardiac Allotransplantation Model

    K. Uchida, K. Fujimoto, E. Yin, H. Bashuda, K. Okumura, K. Takeda

    Juntendo University Atopy Research Center, Tokyo, Japan

    *Purpose: Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population that have the ability to cause immunosuppression. In recent years, MDSCs have attracted attention as a…
  • « Previous Page
  • 1
  • …
  • 657
  • 658
  • 659
  • 660
  • 661
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences